Page last updated: 2024-12-05
3-bromobenzanthrone
3-Bromobenzanthrone is a synthetic organic compound that is a brominated derivative of benzanthrone. It is a yellow solid that is sparingly soluble in most organic solvents. The compound is synthesized through a multi-step process that involves bromination of benzanthrone. 3-Bromobenzanthrone is a potential precursor to other important organic compounds, including dyes and pharmaceuticals. It has been studied for its potential biological activity and its role in various chemical reactions. The compound has been investigated for its antimicrobial and anti-inflammatory properties, but further research is needed to fully understand its potential applications.'
```
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 6696 |
| SCHEMBL ID | 1983882 |
| MeSH ID | M0454688 |
Synonyms (49)
| Synonym |
|---|
| 3-bromobenz(de)anthracen-7-one |
| brn 1975512 |
| nsc 13976 |
| 3-bromobenz(d,e)anthrone |
| 7h-benz(de)anthracen-7-one, 3-bromo- |
| einecs 201-390-7 |
| 3-bromo-7h-benz(de)anthracen-7-one |
| 3-bromo-7h-benz[de]anthracen-7-one |
| 3-bromobenz[d,e]anthrone |
| 7-bromomesobenzanthrone |
| 3-brombenzanthrone |
| 3-bromobenzanthrone , |
| nsc13976 |
| benzanthrone, 3-bromo- |
| 81-96-9 |
| nsc-13976 |
| wln: l c6666 1a q ivj oe |
| 7h-benz[de]anthracen-7-one, 3-bromo- |
| EU-0000135 |
| AC-11850 |
| 3-bromobenzo[b]phenalen-7-one |
| AKOS001073212 |
| STK801556 |
| 3-bromo-7h-benzo[de]anthracen-7-one |
| A840227 |
| 3-bromo-7h-benz[de]anthracene-7-one |
| BBL010353 |
| 3dh9916fno , |
| 4-07-00-01820 (beilstein handbook reference) |
| unii-3dh9916fno |
| F0266-1973 |
| FT-0615196 |
| 7h-benz[de]anthracen-7-one,3-bromo- |
| SCHEMBL1983882 |
| DTXSID9058860 |
| 3-bromo-benzanthrone |
| W-104192 |
| AE-641/00609011 |
| 3-bromobenz[de]anthrone |
| 7h-benz[de]anthracene-7-one, 3-bromo- |
| mfcd00021094 |
| sr-01000389293 |
| SR-01000389293-1 |
| Z56886929 |
| 3-bromo benzanthrone |
| DS-3440 |
| D97803 |
| EN300-235659 |
| 14-bromotetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one |
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.47
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.47 (24.57) | | Research Supply Index | 2.08 (2.92) | | Research Growth Index | 4.55 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |